Putin claims Russia is close to creating effective cancer vaccines: 'Drugs of a new generation'


President Vladimir Putin said on Wednesday that Russian scientists were close to creating vaccines for cancer that could soon be available to patients.

Putin said in televised comments that “we have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation”.

“I hope that soon they will be effectively used as methods of individual therapy,” he added, speaking at a Moscow forum on future technologies.

VLADIMIR PUTIN IN NEW VIDEO SPARKS CANCER RUMORS OVER INTRAVENOUS MARKS ON HAND

Putin did not specify which types of cancer the proposed vaccines would target, nor how.

Vladimir Putin at podium

Russian president Vladimir Putin said the country is nearing effective cancer vaccines.  (Sputnik/Alexander Kazakov/Pool/REUTERS)

A number of countries and companies are working on cancer vaccines. Last year the UK government signed an agreement with Germany-based BioNTech to launch clinical trials providing “personalized cancer treatments”, aiming to reach 10,000 patients by 2030.

Pharmaceutical companies Moderna and Merck & Co are developing an experimental cancer vaccine that a mid-stage study showed cut the chance of recurrence or death from melanoma – the most deadly skin cancer – by half after three years of treatment.

CLICK HERE TO GET THE FOX NEWS APP

There are currently six licensed vaccines against human  papillomaviruses (HPV) that cause many cancers, including cervical cancer, according to the World Health Organization, as well as vaccines against hepatitis B (HBV), which can lead to liver cancer.

During the coronavirus pandemic, Russia developed its own Sputnik V vaccine against COVID-19 and sold it to a number of countries, although domestically it ran up against widespread public reluctance to get vaccinated.

Putin himself said he had taken Sputnik, in a bid to assure people of its efficacy and safety.

Leave a Reply

Your email address will not be published.